MedTrace Logo

Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device

NCT03290300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2024-02-15

Study results available
· View outcomes & findings →

Summary

Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus

Conditions

  • Nasal Obstruction

Interventions

DEVICE

Vivaer Stylus

Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus

Sponsors & Collaborators

  • Aerin Medical

    lead INDUSTRY

Principal Investigators

  • Scott Wolf, MD · Aerin Medical

  • Ofer Jacobowitz, MD, PhD · ENT and Allergy Associates, Middletown, NY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2022-07-09
Completion
2022-07-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03290300 on ClinicalTrials.gov